Portola Pharmaceuticals Inc  

(Public, NASDAQ:PTLA)   Watch this stock  
Find more results forPTLA
25.61
+0.93 (3.77%)
After Hours: 25.61 0.00 (0.00%)
Jul 29, 4:31pm GMT-4  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 24.64 - 25.93
52 week 19.59 - 31.48
Open 24.68
Vol / Avg. 236,443.00/458,863.00
Mkt cap 1,053.10M
P/E 2.69
Div/yield     -
EPS 9.52
Shares 41.12M
Beta     -
Inst. own 90%
Aug 11, 2014
Q2 2014 Portola Pharmaceuticals, Inc. Earnings Release (Estimated) Add to calendar
Jun 18, 2014
Portola Pharmaceuticals Inc at Wells Fargo Healthcare Conference
May 19, 2014
Portola Pharmaceuticals, Inc. at UBS Global Healthcare Conference
May 16, 2014
Portola Pharmaceuticals, Inc. Annual Shareholder Meeting
May 15, 2014
Portola Pharmaceuticals, Inc. at Bank of America Merrill Lynch Health Care Conference - Webcast
May 12, 2014
Q1 2014 Portola Pharmaceuticals, Inc. Financial Results Conference Call - Webcast
May 12, 2014
Q1 2014 Portola Pharmaceuticals, Inc. Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin -1295.36% -791.49%
Operating margin -1307.93% -799.34%
EBITD margin - -785.68%
Return on average assets -38.16% -35.34%
Return on average equity -43.58% -159.12%
Employees 70 -
CDP Score - -

Address

270 E. Grand Avenue
SOUTH SAN FRANCISCO, CA 94080
United States - Map
+1-650-2467000 (Phone)
+1-650-2467376 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Portola Pharmaceuticals, Inc. (Portola) is a biopharmaceutical company developing product candidates that have the potential to represent advances in the fields of thrombosis and hematology. The Company is advancing its three wholly owned programs using biomarker and genetic approaches.

Officers and directors

Charles J. Homcy M.D. Co-Chairman of the Board
Age: 65
Bio & Compensation  - Reuters
Hollings C. Renton III Independent Co-Chairman of the Board
Age: 67
Bio & Compensation  - Reuters
William Lis Chief Executive Officer, Director
Age: 49
Bio & Compensation  - Reuters
Mardi C. Dier Chief Financial Officer, Executive Vice President
Age: 49
Bio & Compensation  - Reuters
John T. Curnutte M.D. Ph.D. Executive Vice President - Research & Development
Age: 61
Bio & Compensation  - Reuters
Peter Strumph Vice President - Technical and Clinical Operations
Bio & Compensation  - Reuters
John H. Johnson Director
Age: 56
Bio & Compensation  - Reuters
Jeffrey W. Bird M.D., Ph.D. Independent Director
Age: 53
Bio & Compensation  - Reuters
Robert C. Califf M.D. Independent Director
Age: 63
Bio & Compensation  - Reuters
Nicholas G. Galakatos Ph.D. Independent Director
Age: 56
Bio & Compensation  - Reuters